Chambers Rebecca (CIK 1823563) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy VCYT (36,181 shares), Buy VCYT (13,157 shares), Sell VCYT (4,400 shares), Sell VCYT (13,941 shares), Sell VCYT (7,234 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Buy | 36,181 | $0 |
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Buy | 13,157 | $0 |
| 2026-03-06 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 4,400 | $156,420 |
| 2026-03-06 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 13,941 | $506,477 |
| 2026-03-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 7,234 | $260,496 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Buy | 59,324 | $0 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 12,049 | $466,899 |
| 2025-12-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 3,384 | $156,205 |
| 2025-12-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 8,537 | $397,910 |
| 2025-12-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 4,741 | $224,012 |
| 2025-11-07 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 7,000 | $287,000 |
| 2025-09-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 5,371 | $161,721 |
| 2025-06-04 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 5,370 | $143,594 |
| 2025-03-10 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Buy | 30,200 | $0 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Buy | 23,170 | $0 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 11,911 | $403,068 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 11,070 | $384,793 |
| 2025-02-19 | Inari Medical, Inc. (NARI) | Director | Sell | 9,684 | $0 |
| 2025-02-05 | VERACYTE, INC. (VCYT) | Chief Financial Officer | Sell | 527 | $23,109 |
Source: SEC Form 4 filings · as of 2026-03-10